I'm working in...
Arrow for button
Cross Arrow

I'm working in...

Role
Company
Select

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Katrina Rice, Chief Delivery Officer, Biometrics Services, eClinical Solutions

Our industry often expects results from technology without enough upfront attention to the problems we’re trying to solve and the anticipated outcomes. Taking time for this advance work is critical to operationalizing digital technologies for meaningful impact. As a clinical biometrics services organization using our own data cloud, elluminate, and many other digital technologies to produce ROI for clients, we’ve been through this tech adoption journey internally and help biopharma clients do the same. The reason to keep coming back to your problem statement is to use that as a driver for defining success –– is it efficiency, quality, speed? We want all of the above, but you need starting metrics to measure how digitally connected operations will improve outcomes. Developing incremental but high-impact ways to produce results that matter to each biopharma organization will accelerate industry-wide goals of high-quality data and faster cycle times. Technology providers can help the industry digitally transform by working with clients on a metrics-first approach, advising on impacts of non-technical factors like misalignment and communication silos, and offering expertise to tackle these derailers. Jointly working to embed metrics across the data life cycle can help the pharmaceutical industry move beyond acceleration goals to downstream impacts.

Read the full article.


By submitting, you agree to the processing of your personal data by eClinical Solutions as described in our Privacy Policy.

Tags: